Myeloma, also known as multiple myeloma, it can be benign and malignant, is a blood cancer arising from plasma cells. At any one time there are around 17,500 people living with myeloma in the UK. It accounts for 15 per cent of blood cancers, and two per cent of all cancers. Myeloma mainly affects those over the age of 65, however it has been diagnosed in people as young as 20.

Sub- tracks: 

1. Multiple Myeloma

2. Signal Transduction

3. Metastatic Cancer

4. Hematologic Cancer

5. Signaling Pathway

6. Information on Drugs

7.  Medicine for Inflammation

Coronavirus Conference | Covid-19 Pandemic | Latest invention and Researches on Covid-19 | World Infectious Diseases 2021

    Related Conference of Myeloma

    January 24-25, 2022

    2nd European Congress on Hematology

    Prague, Czech Republic
    January 24-25, 2022

    2nd World Congress on Hematology and Genetic Blood Disorders

    Prague, Czech Republic
    March 14-15, 2022

    20th World Hematology Congress

    London, UK

    Myeloma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in